Umbrella Administrative Trial Rules and Trial Practice Guide

The following comments have been submitted in response to Rules of Practice for Trials before the Patent Trial and Appeal Board and Judicial Review of Patent Trial and Appeal Board Decisions, 77 Fed. Reg. 6879 (Feb. 9, 2012) and Practice Guide for Proposed Trial Rules, 77 Fed. Reg. 6868 (Feb. 9, 2012) Provision of the Leahy-Smith America Invents Act.

Please note that the following documents are posted as originally received but may contain artifacts of scanning, OCR, or document format conversion.

Intellectual Property Organizations

American Bar Association (2012APR5)

American Bar Association Section of Intellectual Property Law, American Intellectual Property Law Association, and Intellectual Property Owners Association (2012APR9)

American Intellectual Property Law Association 4 (2012APR6)

American Intellectual Property Law Association 5 (2012APR9)

Association of Corporate Counsel (2012APR9)

CONNECT 2 (2012APR10)

CONNECT 1 (2012APR9)

Innovation Alliance 2 (2012APR10)

Japan Intellectual Property Association 1 (2012APR9)

Japan Intellectual Property Association 2 (2012APR9)

Japan Patent Attorneys Association 2 (2012MAR29)

Minnesota Intellectual Property Law Association 2 (2012APR10)

Minnesota Intellectual Property Law Association 2 (2012APR9)

Public Patent Foundation 2 (2012APR10)

Public Patent Foundation 3 (2012APR10)

Public Patent Foundation 1 (2012APR9)

Academic and Research Institutions

IEEE 2 (2012APR17)

Law Firms

Foley and Lardner LLP (2012APR9)

Hunton and Williams (2012APR9)

Oblon, Spivak, McClelland, Maier and Neustadt 1 (2012APR10)

Oliff and Berridge 3 (2012APR11)

Oliff and Berridge 1 (2012APR9)

Schwegman, Lundberg and Woessner 3 (2012APR11)

Schwegman, Lundberg and Woessner 1 (2012APR9)

Sterne, Kessler, Goldstein and Fox 2 (2012APR10)

Sterne, Kessler, Goldstein and Fox 1 (2012APR9)

Companies

Asklepion Pharmaceuticals and Neos Therapeutics (2012APR9)

Business Software Alliance 1 (2012APR9)

Cummins Allison Corp (2012APR9)

Financial Services Roundtable et al (2012APR10)

Genentech 2 (2012APR9)

IBM 5 (2012APR6)

IBM 6 (2012APR6)

Independent Community Bankers of America (2012APR10)

Intel Corporation (2012APR10)

Intellectual Ventures LLC 4 (2012APR9)

Microsoft 1 (2012APR10)

Microsoft 3 (2012APR10)

Novartis Corporation 2 (2012APR9)

Novo Nordisk (2012APR9)

Pharmaceutical Research and Manufacturers of America (2012APR10)

Regulatory Checkbook (2012APR9)

Research In Motion 1 (2012APR9)

Research In Motion 2 (2012APR9)

Verizon, Google, Cisco, Intuit, and Symantec (2012APR9)

Individuals

Burchfiel, Kenneth (2012APR10)

DiCarlo, Paul (2012MAR5)

Fitzpatrick, Michael J. (2012APR9)

Hayden, Craig W. (2012APR7)

Jonathan R. Sick and Herbert D. Hart III (2012APR9)

Lelkes, Robert 1 (2012APR9)

Linck, Nancy J. 1 (2012APR9)

Lindeen, Gordon 2 (2012FEB17)

Lindeen, Gordon 3 (2012FEB17)

Lindeen, Gordon 1 (2012FEB17)

Matthew Smith and Andrew Baluch (2012APR5)

Miller, Charles E. (2012APR9)

Millet, Marcus J. 1 (2012APR9)

Millet, Marcus J. 2 (2012APR9)

Neifeld, Rick (2012MAR27)

Nixon, Dale (2012MAR12)

Phipps, Daima (2012APR9)

Sandip Patel, Michael Goldman and Michael Fitzpatrick (2012APR11)

Stoner, Bruce (2012APR9)

Sundby, Suzannah 1 (2012APR10)

Vepachedu, Rao (2012MAR23)

Walsh, Edmund J. (2012APR9)